Benchmark Holdings plc Stock

Equities

BMK

GB00BGHPT808

Fishing & Farming

Market Closed - London S.E. 11:35:14 2024-05-29 am EDT 5-day change 1st Jan Change
44.5 GBX -0.56% Intraday chart for Benchmark Holdings plc -5.32% +30.69%
Sales 2024 * 164M 210M Sales 2025 * 194M 248M Capitalization 331M 423M
Net income 2024 * -10M -12.77M Net income 2025 * 1M 1.28M EV / Sales 2024 * 2.38 x
Net Debt 2024 * 60.5M 77.24M Net Debt 2025 * 46.5M 59.37M EV / Sales 2025 * 1.95 x
P/E ratio 2024 *
-34.7 x
P/E ratio 2025 *
39.5 x
Employees 823
Yield 2024 *
-
Yield 2025 *
-
Free-Float 71.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.56%
1 week-2.82%
Current month-0.56%
3 months-3.87%
6 months+27.13%
Current year+31.42%
More quotes
1 week
43.00
Extreme 43
46.71
1 month
42.03
Extreme 42.029
47.74
Current year
33.30
Extreme 33.295
48.00
1 year
33.15
Extreme 33.15
48.00
3 years
33.00
Extreme 33
65.90
5 years
24.00
Extreme 24
68.00
10 years
24.00
Extreme 24
125.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 20-05-31
Director of Finance/CFO 47 19-10-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 47 19-03-13
Director/Board Member 49 23-04-16
Chairman 63 18-05-07
More insiders
Date Price Change Volume
24-05-29 44.5 -0.56% 3,639
24-05-28 44.75 -0.56% 17,725
24-05-24 45 +2.97% 65,334
24-05-23 43.7 -7.02% 310,602
24-05-22 47 +2.06% 12,002

Delayed Quote London S.E., May 28, 2024 at 11:35 am EDT

More quotes
Benchmark Holdings plc is a United Kingdom-based aquaculture biotechnology company. The Company is focused on providing specialized mission-critical solutions in three complementary areas: genetics, health, and advanced nutrition. The Company operates through three segments: Genetics, Advanced Nutrition, and Health. The Genetics segment is salmon breeding technology combined with production facilities to provide a range of genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The Company has portfolio of various aquaculture species, such as salmon, shrimp, sea bass and sea bream, and tilapia in all the aquaculture regions around the world.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.4475 GBP
Average target price
0.543 GBP
Spread / Average Target
+21.34%
Consensus